Journal
BIOMIMETICS
Volume 8, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/biomimetics8020155
Keywords
cell delivery; cell-loaded beads; microbeads; encapsulation
Ask authors/readers for more resources
Cell transplants in therapeutic studies cannot maintain long-term function inside the donor body. In this study, fibroblasts and MSCs were encapsulated inside alginate microbeads and showed improved viability and functionality during an incubation period of up to 12 days. The encapsulation strategy has the potential to be a promising cell delivery platform for cell therapy-based tissue engineering.
Cell transplants in therapeutic studies do not preserve their long-term function inside the donor body. In mesenchymal stem cell (MSC) transplants, transplanted cells disperse through the body and are prone to degradation by immune cells after the transplant process. Various strategies, such as usage of the immunosuppressive drugs to eliminate allograft rejection, are designed to increase the efficiency of cell therapy. Another strategy is the construction of biomimetic encapsulates using polymeric materials, which isolate stem cells and protect them from environmental effects. In this study, fibroblasts (L929) and MSCs were investigated for their improved viability and functionality once encapsulated inside the alginate microbeads under in vitro conditions for up to 12 days of incubation. Thus, uniform and injectable (<200 & mu;m) cell-loaded microbeads were constructed by the electrostatically assisted spraying technique. Results showed that both L929 and MSCs cells continue their metabolic activity inside the microbeads during the incubation periods. Glucose consumption and lactic acid production levels of both cell lines were consistently observed. The released cell number on day 12 was found to be increased compared to day 0. Protein expression levels of both groups increased every day with the expected doubling rate. Hence, this strategy with a simple yet clever design to encapsulate either MSCs or L929 cells might outstand as a potential cell delivery platform for cell therapy-based tissue engineering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available